Explore the latest advances in alopecia areata treatment, including FDA-approved JAK inhibitors and promising topical ...

Guidelines have been established regarding the definition, diagnosis, and management of persistent chemotherapy-induced alopecia.

Baricitinib (Olumiant; Eli Lilly), an oral Janus kinase (JAK) 1/2 inhibitor, led to significant scalp, eyelash, and eyebrow hair regrowth at 52 weeks in adolescents with severe alopecia areata, ...

Ritlecitinib effectively reduces psychosocial burden in severe alopecia areata, beyond hair regrowth benefits. Significant improvements in emotional symptoms and activity limitations were observed ...

Biotech investors have not often looked at a balding head of hair and been struck with inspiration, even on the rare ...

How one woman went from a severe alopecia areata diagnosis to finding the right prescription treatment for her—and getting ...

Explore how alcohol consumption affects alopecia areata, and learn about safe drinking guidelines and support resources.

Fifty-four percent of patients ages 12 to 18 with severe alopecia noticed hair regrowth when given 4-mg of Olumiant (oral baricitinib), according to results of a study presented this week at the 2025 ...

Some people embrace their baldness, but others are hoping for a cure. A team of researchers thinks the latter might soon be in reach. The researchers at the San Carlos Clinical Hospital in Madrid ...

Low-dose oral minoxidil effectively promotes hair regrowth in breast cancer patients with chemotherapy-induced alopecia, without significant cardiovascular risks. A study of 51 patients showed ...

This article was reviewed by Knox Beasley, MD. Retrograde alopecia is a form of hair loss characterized by the gradual thinning or recession of hair at the nape of the neck or the sides of the scalp.